Medical Weight Loss Treatment for Florida Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers hold active Florida Board of Medicine licenses, ensuring compliant telehealth delivery across all 67 counties.
Whether you're in Jacksonville, Tallahassee, or anywhere across Florida — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Florida
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
The Sunshine State's diverse population deserves healthcare as dynamic as Florida itself. From the retirees of The Villages to the young professionals of Miami, the families of Tampa Bay to the snowbirds of Naples, OmniRx Health serves all Floridians. Our telehealth platform eliminates traffic jams on I-95, waits at crowded clinics, and the challenge of finding specialists in rural areas—bringing expert care directly to your lanai, condo, or beach house.
Available Treatments in Florida
Our board-certified providers in Florida can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Florida
State Licensing
OmniRx Health providers hold active Florida Board of Medicine licenses, ensuring compliant telehealth delivery across all 67 counties.
Telehealth Law
Florida's telehealth laws are comprehensive, allowing licensees to practice across the state via secure video platforms with full prescriptive authority.
Pharmacy Access
Florida's extensive pharmacy network—from Miami to Jacksonville to the Panhandle—ensures rapid prescription fulfillment with convenient home delivery options.
Insurance Notes
Florida requires telehealth coverage parity for most insurance plans, and Medicare's expanded telehealth benefits serve the state's significant 65+ population.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Florida
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.